246 related articles for article (PubMed ID: 27966459)
21. Prognostic values of S100 family mRNA expression in ovarian cancer.
Ma N; Zhu L; Yang L; Cui Y; Zhan Y
Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
[TBL] [Abstract][Full Text] [Related]
22. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract][Full Text] [Related]
23. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.
Chiao CC; Liu YH; Phan NN; An Ton NT; Ta HDK; Anuraga G; Minh Xuan DT; Fitriani F; Putri Hermanto EM; Athoillah M; Andriani V; Ajiningrum PS; Wu YF; Lee KH; Chuang JY; Wang CY; Kao TJ
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943457
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types.
Larsson P; Pettersson D; Engqvist H; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ
BMC Cancer; 2022 Sep; 22(1):993. PubMed ID: 36123629
[TBL] [Abstract][Full Text] [Related]
26. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
Li J; Wang J; Chen Y; Yang L; Chen S
J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.
Huang C; Liu J; Xiong B; Yonemura Y; Yang X
Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009
[TBL] [Abstract][Full Text] [Related]
28. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
Xia P; Xu XY
Oncotarget; 2016 Jul; 7(29):45538-45546. PubMed ID: 27323782
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.
Xie S; Shen C; Tan M; Li M; Song X; Wang C
Oncotarget; 2017 Apr; 8(16):27216-27239. PubMed ID: 28423713
[TBL] [Abstract][Full Text] [Related]
32. PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.
Kwon CH; Park HJ; Choi YR; Kim A; Kim HW; Choi JH; Hwang CS; Lee SJ; Choi CI; Jeon TY; Kim DH; Kim GH; Park do Y
Oncotarget; 2016 Apr; 7(16):21454-68. PubMed ID: 26894977
[TBL] [Abstract][Full Text] [Related]
33. Systematic Characterization of the Expression and Prognostic Values of Formin-Like Gene Family in Gastric Cancer.
Nie H; Mei J; Zhang Q; An F; Zhan Q
DNA Cell Biol; 2020 Sep; 39(9):1664-1677. PubMed ID: 32551946
[TBL] [Abstract][Full Text] [Related]
34. The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels.
Bachmann HS; Novotny J; Sixt S; Liebisch P; Frey UH; Dührsen U; Siffert W; Nückel H
Eur J Haematol; 2010 Aug; 85(2):108-13. PubMed ID: 20408869
[TBL] [Abstract][Full Text] [Related]
35. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Li Y; Guo M; Fu Z; Wang P; Zhang Y; Gao Y; Yue M; Ning S; Li D
Oncotarget; 2017 Jan; 8(2):2444-2456. PubMed ID: 27911271
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
38. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
Wang H; Chong T; Li BY; Chen XS; Zhen WB
Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
[TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer.
Cui X; Jing X; Yi Q; Long C; Tan B; Li X; Chen X; Huang Y; Xiang Z; Tian J; Zhu J
Oncotarget; 2018 Jan; 9(3):3198-3213. PubMed ID: 29423040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
